- Home
- >
- Technical Documentation File
- >
- Clinical Evaluation & MDR
Clinical Evaluation for medical devices under MDR
Unlock European Market Access with Reliable, MDR-Compliant Clinical Evaluations.
At BioTop Medical, we deliver structured, systematic, and objective clinical evaluations that fully comply with the European Medical Device Regulation (MDR, EU 2017/745), Annex XIV, Part A. Whether you’re developing a Clinical Evaluation Plan (CEP), assessing post-market clinical data, or considering a clinical investigation, our expert team ensures your documentation meets both regulatory expectations and scientific best practices.
All deliverables are prepared in a structured, audit-ready format.
Comprehensive Clinical Evaluation Support Under MDR
We offer in-depth support for clinical evaluation as required by the MDR. Our expertise covers the entire clinical evaluation lifecycle—from planning and literature searches to clinical data analysis and report writing. Every evaluation is methodologically sound and tailored to fulfill the requirements of Annex XIV of the MDR.
We collaborate closely with clients to understand their device’s intended purpose and clinical application. This approach ensures evaluations are both technically accurate and regulatory compliant—paving the way for CE marking.
Clinical evaluation: a key element for MDR compliance
Clinical evaluation is an ongoing process of collecting, appraising, and analyzing clinical data to monitor the safety and performance of a medical device. Under the MDR, it is required not only for new devices but also throughout the product lifecycle.
For MDR-compliant evaluations, the following is required:
- Clinical Evaluation Plan (CEP):
- A systematic literature search to confirm that the device represents the current state-of-the-art
- A Clinical Development Plan outlining the strategy to generate necessary clinical data to support the claimed performance, safety, and benefit
- Clinical Evaluation Report (CER):
- Identification of pertinent clinical data (data sets) from multiple sources, such as:
- Scientific literature,
- Clinical investigations,
- Post-market surveillance (PMS) data, and
- Legacy data from earlier CE marked devices.
- Appraisal and data extraction following the methodology outlined in the CEP
- Demonstration of conformity with the General Safety and Performance Requirements (GSPRs), as required in the CEP.
- Clear documentation of the assessment and conclusions
- Identification of pertinent clinical data (data sets) from multiple sources, such as:
Our methodology ensures full traceability between data sources, appraisal outcomes, and conclusions.
Understanding Clinical Benefit
Clinical benefit refers to the positive impact on patient health, as intended by the manufacturer. MDR requires manufacturers to demonstrate not only device performance but also clinical benefit—particularly in comparison with alternative solutions available on the market.
Examples of clinical benefits are:
- Faster or more effective treatment
- Increased diagnostic accuracy
- Reduced disease risk or severity
- Improved patient quality of life
Our evaluation reports provide clear, evidence-based documentation to support your claimed clinical benefits.
Clinical Investigation vs. Clinical Evaluation
A clinical investigation is a planned, systematic study involving human subjects to generate new clinical data. It is often necessary to demonstrate a device clinical performance, safety, and benefit.
A clinical evaluation, on the other hand, assesses existing clinical data—including investigation reports—to establish the device’s performance, safety, and benefit-risk profile for its claimed intended use.
We support clients in determining whether a clinical investigation is required (per Article 62 of the MDR). If it is, we assist in developing the study protocol, managing submissions, and preparing the final report.
Get in touch!
Why BioTop Medical?
Questions? Contact us
For direct contact call
+31 (0)71 528 01 12
You can also email us
info@biotopmedical.nl
FAQ about Clinical evaluation & MDR
My product is a class I medical device, do I need to have Technical Documentation File?
Yes, all medical devices—including Class I—must have a Technical Documentation File demonstrating compliance with the applicable requirements of the Medical Device Regulation (EU) 2017/745. The file must be available to the Competent Authority during their inspection of medical devices companies.
Does my company need to have a EN ISO 13485 certified quality system management?
A certified QMS is not always legally required, but all manufacturers must implement a Quality Management System (QMS) that meets the requirements of MDR Article 10. While for Class I devices that will be sufficient, Class IIa, IIb, and III manufacturers are generally expected to operate under a ISO 13485 certified QMS. For many Notified Bodies, certification is in fact a prerequisite for CE marking of higher-risk devices.
There are already a number of similar devices in the market, do I need a clinical trial?
Not necessarily. For example, if your device falls under the exemptions of MDR Article 61(6)(b), or if you can demonstrate equivalence to another CE-marked device and provide sufficient clinical data to support the safety, performance, and clinical benefits of your own device, a clinical trial may not be required. However, if the available data is insufficient, or if your device introduces new risks, technologies, or clinical indications, a clinical investigation will be required in accordance with MDR requirements.
I need a literature search, can someone at the company do that? Or do I need to outsource it to prevent bias?
Yes, someone within your company can perform the literature search, as long as the process is conducted in a systematic, objective, and reproducible way, following the requirements of MEDDEV 2.7/1 rev. 4 and Annex XIV of the MDR. It is not mandatory to outsource the task to prevent bias, but you must ensure that the search strategy, selection criteria, and appraisal of the data are well-documented and justifiable. Having the literature search performed by someone not employed by the company can help strengthen the objectivity and credibility of the results.
When do I know if I have ``sufficient`` clinical evidence, as is asked in Article 61(1) of the MDR?
There is no clear-cut answer for this question. “How much is enough” depends on several factors, such as the risk class of the device, the novelty of the technology, the intended use and clinical claims, the results of risk management, the target population. Ultimately, the level of evidence must be sufficient to demonstrate safety, performance, and clinical benefit — and be acceptable to the Notified Body.
Is a Post – Market Clinical Follow-up (PMCF) study always a clinical trial?
No. Other common PMCF activities include PMCF-specific questionnaires or surveys, registries, literature reviews, analysis of real-world clinical data, e.g., from complaints, adverse events, or usage patterns.